| Symbol: |
ARHGAP35
|
| Description: |
Rho GTPase activating protein 35 [Source:HGNC Symbol;Acc:4591]
|
| Location: |
Chr19:47421933-47508323[+]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:266
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| ARHGAP35 |
NSC 720258 |
0.008 |
Up |
| ARHGAP35 |
1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole |
0.037 |
Down |
| ARHGAP35 |
N-(6'-Chrysenyl)-4-(1'-piperidinyl)-D-2,3-dioxalono-butane-1 ,4-dicarboximide |
0.034 |
Up |
| ARHGAP35 |
3'-C-ethinylcytidine |
0.002 |
Up |
| ARHGAP35 |
S-(dimethylarsino)-3-mercapto-1,2-propyl dibenzoate |
0.002 |
Up |
| ARHGAP35 |
2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid |
0.013 |
Up |
| ARHGAP35 |
NSC 725127 |
0.004 |
Up |
| ARHGAP35 |
6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.021 |
Up |
| ARHGAP35 |
NSC 726260 |
0.017 |
Up |
| ARHGAP35 |
4,11-dihydroxy-1-[4-(4-hydroxy-1-piperidinyl)butyl]-1H-napht ho[2,3-f]indole-5,10-dione |
0.002 |
Up |
| ARHGAP35 |
1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one |
0.046 |
Up |
| ARHGAP35 |
2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide |
0.002 |
Up |
| ARHGAP35 |
Dasatinib |
0.009 |
Down |
| ARHGAP35 |
NSC 732719 |
0.017 |
Up |
| ARHGAP35 |
NSC 732956 |
0.011 |
Up |
Expression pattern: Sensitivity / Resistance
Total:18 Current:16
First Prev Next Last
|
| SNP:
~ Export ~
|
Records:68
Total:5 Current:1
[First] [Prev] Next Last
|
| miRNA:
~ Export ~
|
Records:null
| Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|